The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Candesartan and Hydrochlorothiazide-Global Market Insights and Sales Trends 2025
Synopsis
Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
The global Candesartan and Hydrochlorothiazide market size is expected to reach US$ 470.1 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Candesartan and Hydrochlorothiazide in various end use industries. The expanding demands from the Adults and Geriatric, are propelling Candesartan and Hydrochlorothiazide market. 16/12.5, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 32/12.5 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Candesartan and Hydrochlorothiazide market, driven by demand from China, the second largest economy with some signs of stabilising, the Candesartan and Hydrochlorothiazide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Candesartan and Hydrochlorothiazide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Candesartan and Hydrochlorothiazide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Candesartan and Hydrochlorothiazide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Candesartan and Hydrochlorothiazide covered in this report include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc.
The global Candesartan and Hydrochlorothiazide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
ANI Pharmaceuticals
TEVA
Mylan
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
MACLEODS
Global Candesartan and Hydrochlorothiazide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Candesartan and Hydrochlorothiazide market, Segment by Type:
16/12.5
32/12.5
32/25
Global Candesartan and Hydrochlorothiazide market, by Application
Adults
Geriatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
The global Candesartan and Hydrochlorothiazide market size is expected to reach US$ 470.1 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Candesartan and Hydrochlorothiazide in various end use industries. The expanding demands from the Adults and Geriatric, are propelling Candesartan and Hydrochlorothiazide market. 16/12.5, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 32/12.5 segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Candesartan and Hydrochlorothiazide market, driven by demand from China, the second largest economy with some signs of stabilising, the Candesartan and Hydrochlorothiazide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Candesartan and Hydrochlorothiazide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Candesartan and Hydrochlorothiazide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Candesartan and Hydrochlorothiazide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Candesartan and Hydrochlorothiazide covered in this report include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc.
The global Candesartan and Hydrochlorothiazide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
ANI Pharmaceuticals
TEVA
Mylan
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
MACLEODS
Global Candesartan and Hydrochlorothiazide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Candesartan and Hydrochlorothiazide market, Segment by Type:
16/12.5
32/12.5
32/25
Global Candesartan and Hydrochlorothiazide market, by Application
Adults
Geriatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Candesartan and Hydrochlorothiazide Market Overview
1.1 Candesartan and Hydrochlorothiazide Product Overview
1.2 Candesartan and Hydrochlorothiazide Market Segment by Type
1.2.1 16/12.5
1.2.2 32/12.5
1.2.3 32/25
1.3 Global Candesartan and Hydrochlorothiazide Market Size by Type
1.3.1 Global Candesartan and Hydrochlorothiazide Market Size Overview by Type (2018-2029)
1.3.2 Global Candesartan and Hydrochlorothiazide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Breakdown by Type (2018-2023)
2 Global Candesartan and Hydrochlorothiazide Market Competition by Company
2.1 Global Top Players by Candesartan and Hydrochlorothiazide Sales (2018-2023)
2.2 Global Top Players by Candesartan and Hydrochlorothiazide Revenue (2018-2023)
2.3 Global Top Players by Candesartan and Hydrochlorothiazide Price (2018-2023)
2.4 Global Top Manufacturers Candesartan and Hydrochlorothiazide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Candesartan and Hydrochlorothiazide Market Competitive Situation and Trends
2.5.1 Candesartan and Hydrochlorothiazide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Candesartan and Hydrochlorothiazide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Candesartan and Hydrochlorothiazide as of 2022)
2.7 Date of Key Manufacturers Enter into Candesartan and Hydrochlorothiazide Market
2.8 Key Manufacturers Candesartan and Hydrochlorothiazide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Candesartan and Hydrochlorothiazide Status and Outlook by Region
3.1 Global Candesartan and Hydrochlorothiazide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Candesartan and Hydrochlorothiazide Historic Market Size by Region
3.2.1 Global Candesartan and Hydrochlorothiazide Sales in Volume by Region (2018-2023)
3.2.2 Global Candesartan and Hydrochlorothiazide Sales in Value by Region (2018-2023)
3.2.3 Global Candesartan and Hydrochlorothiazide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Region
3.3.1 Global Candesartan and Hydrochlorothiazide Sales in Volume by Region (2024-2029)
3.3.2 Global Candesartan and Hydrochlorothiazide Sales in Value by Region (2024-2029)
3.3.3 Global Candesartan and Hydrochlorothiazide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Candesartan and Hydrochlorothiazide by Application
4.1 Candesartan and Hydrochlorothiazide Market Segment by Application
4.1.1 Adults
4.1.2 Geriatric
4.2 Global Candesartan and Hydrochlorothiazide Market Size by Application
4.2.1 Global Candesartan and Hydrochlorothiazide Market Size Overview by Application (2018-2029)
4.2.2 Global Candesartan and Hydrochlorothiazide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Candesartan and Hydrochlorothiazide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Candesartan and Hydrochlorothiazide Sales Breakdown by Application (2018-2023)
5 North America Candesartan and Hydrochlorothiazide by Country
5.1 North America Candesartan and Hydrochlorothiazide Historic Market Size by Country
5.1.1 North America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Candesartan and Hydrochlorothiazide Sales in Volume by Country (2018-2023)
5.1.3 North America Candesartan and Hydrochlorothiazide Sales in Value by Country (2018-2023)
5.2 North America Candesartan and Hydrochlorothiazide Forecasted Market Size by Country
5.2.1 North America Candesartan and Hydrochlorothiazide Sales in Volume by Country (2024-2029)
5.2.2 North America Candesartan and Hydrochlorothiazide Sales in Value by Country (2024-2029)
6 Europe Candesartan and Hydrochlorothiazide by Country
6.1 Europe Candesartan and Hydrochlorothiazide Historic Market Size by Country
6.1.1 Europe Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Candesartan and Hydrochlorothiazide Sales in Volume by Country (2018-2023)
6.1.3 Europe Candesartan and Hydrochlorothiazide Sales in Value by Country (2018-2023)
6.2 Europe Candesartan and Hydrochlorothiazide Forecasted Market Size by Country
6.2.1 Europe Candesartan and Hydrochlorothiazide Sales in Volume by Country (2024-2029)
6.2.2 Europe Candesartan and Hydrochlorothiazide Sales in Value by Country (2024-2029)
7 Asia-Pacific Candesartan and Hydrochlorothiazide by Region
7.1 Asia-Pacific Candesartan and Hydrochlorothiazide Historic Market Size by Region
7.1.1 Asia-Pacific Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Candesartan and Hydrochlorothiazide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Candesartan and Hydrochlorothiazide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Candesartan and Hydrochlorothiazide Forecasted Market Size by Region
7.2.1 Asia-Pacific Candesartan and Hydrochlorothiazide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Candesartan and Hydrochlorothiazide Sales in Value by Region (2024-2029)
8 Latin America Candesartan and Hydrochlorothiazide by Country
8.1 Latin America Candesartan and Hydrochlorothiazide Historic Market Size by Country
8.1.1 Latin America Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Candesartan and Hydrochlorothiazide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Candesartan and Hydrochlorothiazide Sales in Value by Country (2018-2023)
8.2 Latin America Candesartan and Hydrochlorothiazide Forecasted Market Size by Country
8.2.1 Latin America Candesartan and Hydrochlorothiazide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Candesartan and Hydrochlorothiazide Sales in Value by Country (2024-2029)
9 Middle East and Africa Candesartan and Hydrochlorothiazide by Country
9.1 Middle East and Africa Candesartan and Hydrochlorothiazide Historic Market Size by Country
9.1.1 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Candesartan and Hydrochlorothiazide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Candesartan and Hydrochlorothiazide Forecasted Market Size by Country
9.2.1 Middle East and Africa Candesartan and Hydrochlorothiazide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Candesartan and Hydrochlorothiazide Products Offered
10.1.5 AstraZeneca Recent Development
10.2 ANI Pharmaceuticals
10.2.1 ANI Pharmaceuticals Company Information
10.2.2 ANI Pharmaceuticals Introduction and Business Overview
10.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Products Offered
10.2.5 ANI Pharmaceuticals Recent Development
10.3 TEVA
10.3.1 TEVA Company Information
10.3.2 TEVA Introduction and Business Overview
10.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 TEVA Candesartan and Hydrochlorothiazide Products Offered
10.3.5 TEVA Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Candesartan and Hydrochlorothiazide Products Offered
10.4.5 Mylan Recent Development
10.5 Dr. Reddy's Laboratories
10.5.1 Dr. Reddy's Laboratories Company Information
10.5.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Products Offered
10.5.5 Dr. Reddy's Laboratories Recent Development
10.6 Zydus Pharmaceuticals
10.6.1 Zydus Pharmaceuticals Company Information
10.6.2 Zydus Pharmaceuticals Introduction and Business Overview
10.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Products Offered
10.6.5 Zydus Pharmaceuticals Recent Development
10.7 Prinston Pharmaceutical
10.7.1 Prinston Pharmaceutical Company Information
10.7.2 Prinston Pharmaceutical Introduction and Business Overview
10.7.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Products Offered
10.7.5 Prinston Pharmaceutical Recent Development
10.8 MACLEODS
10.8.1 MACLEODS Company Information
10.8.2 MACLEODS Introduction and Business Overview
10.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MACLEODS Candesartan and Hydrochlorothiazide Products Offered
10.8.5 MACLEODS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Candesartan and Hydrochlorothiazide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Candesartan and Hydrochlorothiazide Industrial Chain Analysis
11.4 Candesartan and Hydrochlorothiazide Market Dynamics
11.4.1 Candesartan and Hydrochlorothiazide Industry Trends
11.4.2 Candesartan and Hydrochlorothiazide Market Drivers
11.4.3 Candesartan and Hydrochlorothiazide Market Challenges
11.4.4 Candesartan and Hydrochlorothiazide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Candesartan and Hydrochlorothiazide Distributors
12.3 Candesartan and Hydrochlorothiazide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
